These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 12393679

  • 1. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.
    Harada H, Harada Y, Tanaka H, Kimura A, Inaba T.
    Blood; 2003 Jan 15; 101(2):673-80. PubMed ID: 12393679
    [Abstract] [Full Text] [Related]

  • 2. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
    Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T.
    Blood; 2004 Mar 15; 103(6):2316-24. PubMed ID: 14615365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.
    Harada H, Harada Y.
    Crit Rev Eukaryot Gene Expr; 2005 Mar 15; 15(3):183-96. PubMed ID: 16390315
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aml1 gene rearrangements and mutations in radiation-associated acute myeloid leukemia and myelodysplastic syndromes.
    Klymenko S, Trott K, Atkinson M, Bink K, Bebeshko V, Bazyka D, Dmytrenko I, Abramenko I, Bilous N, Misurin A, Zitzelsberger H, Rosemann M.
    J Radiat Res; 2005 Jun 15; 46(2):249-55. PubMed ID: 15988144
    [Abstract] [Full Text] [Related]

  • 8. High frequency of AML1/RUNX1 point mutations in radiation-associated myelodysplastic syndrome around Semipalatinsk nuclear test site.
    Zharlyganova D, Harada H, Harada Y, Shinkarev S, Zhumadilov Z, Zhunusova A, Tchaizhunusova NJ, Apsalikov KN, Kemaikin V, Zhumadilov K, Kawano N, Kimura A, Hoshi M.
    J Radiat Res; 2008 Sep 15; 49(5):549-55. PubMed ID: 18724045
    [Abstract] [Full Text] [Related]

  • 9. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y, Harada H.
    J Cell Physiol; 2009 Jul 15; 220(1):16-20. PubMed ID: 19334039
    [Abstract] [Full Text] [Related]

  • 10. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.
    Michaud J, Wu F, Osato M, Cottles GM, Yanagida M, Asou N, Shigesada K, Ito Y, Benson KF, Raskind WH, Rossier C, Antonarakis SE, Israels S, McNicol A, Weiss H, Horwitz M, Scott HS.
    Blood; 2002 Feb 15; 99(4):1364-72. PubMed ID: 11830488
    [Abstract] [Full Text] [Related]

  • 11. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H, Harada H, Harada Y, Ding Y, Imagawa J, Inaba T, Kyo T, Kimura A.
    Leukemia; 2006 Apr 15; 20(4):635-44. PubMed ID: 16467864
    [Abstract] [Full Text] [Related]

  • 12. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.
    Harada H, Harada Y, Kimura A.
    Curr Cancer Drug Targets; 2006 Sep 15; 6(6):553-65. PubMed ID: 17017876
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
    Leroy H, Roumier C, Grardel-Duflos N, Macintyre E, Lepelley P, Fenaux P, Preudhomme C.
    Blood; 2002 May 15; 99(10):3848-50. PubMed ID: 11986246
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T, Taki T, Takita J, Tsuchida M, Hanada R, Hongo T, Kaneko T, Manabe A, Ida K, Hayashi Y.
    Genes Chromosomes Cancer; 2003 Sep 15; 38(1):1-7. PubMed ID: 12874780
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.
    Asou N.
    Crit Rev Oncol Hematol; 2003 Feb 15; 45(2):129-50. PubMed ID: 12604126
    [Abstract] [Full Text] [Related]

  • 20. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis.
    Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Takeuchi K, Maki K, Ogawa S, Chiba S, Mitani K, Hirai H.
    Blood; 2000 Nov 01; 96(9):3154-60. PubMed ID: 11049997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.